Dr. Martens plc (LON:DOCS – Get Free Report) insider Ije Nwokori sold 209,160 shares of the business’s stock in a transaction that occurred on Friday, October 16th. The stock was sold at an average price of GBX 69, for a total value of £144,320.40.
Ije Nwokori also recently made the following trade(s):
- On Monday, October 12th, Ije Nwokori purchased 220 shares of Dr. Martens stock. The stock was acquired at an average price of GBX 68 per share, for a total transaction of £149.60.
- On Friday, September 11th, Ije Nwokori purchased 232 shares of Dr. Martens stock. The shares were acquired at an average cost of GBX 65 per share, with a total value of £150.80.
- On Tuesday, August 11th, Ije Nwokori acquired 179 shares of Dr. Martens stock. The shares were bought at an average cost of GBX 84 per share, with a total value of £150.36.
Dr. Martens Price Performance
LON:DOCS opened at GBX 68.80 on Monday. Dr. Martens plc has a one year low of GBX 59.15 and a one year high of GBX 97.05. The company has a market cap of £658.53 million, a P/E ratio of 28.67, a P/E/G ratio of 6.40 and a beta of 0.26. The firm’s fifty day moving average price is GBX 73.05 and its two-hundred day moving average price is GBX 71.10. The company has a debt-to-equity ratio of 108.85, a current ratio of 2.61 and a quick ratio of 1.13.
Wall Street Analysts Forecast Growth
Separately, Berenberg Bank reiterated a “buy” rating and issued a GBX 110 price target on shares of Dr. Martens in a research note on Friday, October 9th. Two analysts have rated the stock with a Buy rating and one has given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of GBX 105.
Get Our Latest Report on Dr. Martens
About Dr. Martens
Dr. Martens is an iconic British footwear brand founded in Northamptonshire, England. Its first silhouette, the 1460 boot – named after the date it was produced – rolled off the production line on 1st April 1960. Originally chosen by workers for their air-cushioned comfort and durability, “Docs” or “DM’s” were later adopted by musicians and subcultural pioneers who took them from the street to the global stage.
Over six decades later, Dr. Martens operates in more than 60 countries and employs around 3,600 people.
See Also
- Five stocks we like better than Dr. Martens
- These 3 Green Stocks Have a Growth Story That Goes Far Beyond Washington
- Meta Claims Frontier-Class AI Status With New Muse Wonder Models
- Berkshire Just Backed This Little-Known Stock—Should You Chase It?
- Broadcom’s CEO Sees Years of AI Demand But Warns of a Bigger Threat to the Boom
Receive News & Ratings for Dr. Martens Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dr. Martens and related companies with MarketBeat.com's FREE daily email newsletter.
